Law Enforcement

July 14, 2022 | Controlled Substances, Law Enforcement, Legal & Legislative Research, Prescription Drugs, Public Safety

In this survey, the Legislative Analysis and Public Policy Association (LAPPA) examines the state-level legislative response to drugged driving. In Section I, it presents the existing laws on driving under the influence of drugs in the 50 states and the District of Columbia. Section II highlights a selection of additional resources for policymakers on drugged driving research and policy proposals in the United States. These resources include scientific studies, such as the latest research on the physiological effects of certain substances on drivers and the effectiveness of new testing methods and policy analysis, including recommendations from the U.S. Department of Justice on how to effectively detect and prosecute drugged driving. Together they illuminate the evolving landscape of drugged driving in the United States and the potential remedies that can keep Americans safe on the roads....

May 19, 2022 | Controlled Substances, Harm Reduction, Innovative Initiatives, Law Enforcement, Opioids, Prescription Drugs, Public Health, Recovery, Substance Misuse, Treatments

The restaurant industry has been particularly impacted by the opioid epidemic with, for example, ten percent of food service workers dying from opioid overdoses in the State of Delaware.[1] This sobering statistic prompted the Delaware Division of Public Health (DPH) to launch the Restaurant Accolade Program (the Program), which trains all restaurant staff and owners in the state on how to identify, respond to, and reverse an opioid overdose and helps food establishments draft policies that support employees and patrons with substance use disorders (SUDs). The Office of Health Crisis Response (OCHR) within DPH conducts the training and education....

March 28, 2022 | Controlled Substances, Criminal Justice, Drug Courts, Law Enforcement, Opioids, Prescription Drugs, Public Health, Public Safety, Recovery, Reports & Studies, Substance Misuse, Synthetic Drugs

In September 2021, Georgetown University Law Center convened an Opioid Litigation Summit. This convening brought together numerous experts to discuss legal, administrative, and programmatic strategies needed to optimize the impact of proceeds from the opioid litigation. The themes described in this brief emerged from the Summit and can be applied to the opioid litigation as well as future mass tort litigation to address public health crises....

March 3, 2022 | Controlled Substances, Harm Reduction, Innovative Initiatives, Law Enforcement, Opioids, Prescription Drugs, Public Health, Recovery, Substance Misuse, Treatments

When Pennsylvania Attorney General Josh Shapiro learned that approximately 15 citizens of the Commonwealth of Pennsylvania die each day from an overdose, he took action. As a result, in May of 2018, he launched the Law Enforcement Treatment Initiative (LETI) to connect individuals suffering with a substance use disorder (SUD) to treatment resources....

March 2, 2022 | Controlled Substances, Criminal Justice, Drug Courts, First Responders, Harm Reduction, Law Enforcement, Model Laws, Public Health, Public Safety, Recovery, Substance Misuse, Treatments

The Model Law Enforcement and Other First Responder Deflection Act, drafted in collaboration with the Police, Treatment, and Community Collaborative (PTACC), encourages the use and establishment of deflection programs on the state level. Specifically, the model act (1) authorizes law enforcement and other first responders to develop and implement collaborative deflection programs that provide proactive policing to assist individuals who are at risk; (2) offers pathways to treatment, recovery services, housing, medication for addiction treatment, whole family services, and other needed supports; (3) requires deflection programs to have certain threshold elements to be eligible to receive grant funding; and (4) requires agencies establishing deflection programs to develop comprehensive memoranda of understanding in conjunction with, and agreed to by, all deflection program partners....

March 2, 2022 | Controlled Substances, Criminal Justice, Drug Courts, Law Enforcement, Opioids, Public Health, Recovery, Reports & Studies, Substance Misuse, Synthetic Drugs

“Stigma” is defined as stereotypes or negative views attributed to a person or groups of people whose characteristics or behaviors are viewed as different from, or inferior to, societal norms. Surveys of public attitudes about various stigmatizing conditions indicate that individuals with a substance use disorder are viewed more negatively than individuals with a mental disorder. This report, released in collaboration with Rulo Strategies LLC, explores efforts to reduce stigma towards individuals with a substance use disorder in public safety and justice settings....

February 16, 2022 | Controlled Substances, Criminal Justice, Fentanyl, Law Enforcement, Opioids, Reports & Studies, Synthetic Drugs, Trafficking

The Commission on Combating Synthetic Opioid Trafficking, established under Section 7221 of the National Defense Authorization Act for Fiscal Year 2020, was charged with examining aspects of the synthetic opioid threat to the United States—specifically, with developing a consensus on a strategic approach to combating the illegal flow of synthetic opioids into the United States. This final report describes items involving the illegal manufacturing and trafficking of synthetic opioids, as well as the deficiencies in countering their production and distribution, and includes action items directed to appropriate executive branch agencies and congressional committees and leadership....